Libby Dodds Ashley Talks About the Need for New Antibiotics
Many drug companies have announced plans to stop development of antibiotics for financial reasons. In a recent article in Healio, DASON director and Society of Infectious Diseases Pharmacists President Libby Dodds Ashley spoke about the importance of continuing to develop new antibiotics.
It’s the one area that drug companies are abandoning and it’s the one drug class that will always need more drugs. ... It’s unfortunate that many companies are being forced out of that marketplace because of understandable but financial reasons.